Smartphones for Opiate Addiction Recovery
Key facts
- Who runs it
- NYU Langone Health
- Where
- New York and Piscataway, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 225 people, planned
- Started
- 1 Nov 2021
- Expected to end
- 1 Dec 2027
- Type of study
- Interventional, 5 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Smartphone app
- Record updated
- 23 June 2026
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 28 criteriaShow less
Who can take part
- Patients:
- Meet DSM-5 criteria for opioid-use disorder (heroin and/or prescription opioids)
- Have entered, or expressed a clear intention to enter, an OUD treatment program that prescribes either methadone or buprenorphine
- Any gender
- 18 years of age and older
- Have used opioids other than as specifically prescribed within thirty days prior to consent
- In good-enough general health
- Capacity to provide written informed consent as assessed by our Subject Comprehension Assessment Tool(subjects lacking the ability to consent will not be enrolled)
- Able to speak English sufficiently to understand the study procedures and provide written informed consent to participate in the study; Study-Physician Participants
- Licensed MD employed by the respective site, or at a clinical partner of the respective site, where they will act as participants and be part of the treatment team
- Currently practicing in the treatment of OUD with either Buprenorphine or Methadone
- Able to speak, read, and write English fluently and to provide informed consent in English; Clinician Participants
- Licensed MSW, NP, or MD; who are not part of any treatment team within the study and may be employees of their respective sites or other treatment facilities
- Currently practicing in the treatment of OUD with either Buprenorphine or Methadone
- Able to speak, read, and write English fluently and to provide informed consent in English
Who cannot take part
- Individuals receiving residential court-ordered substance abuse treatment; Study-Physician Participants
- Severe, untreated or inadequately treated mental disorder (e.g., active psychosis, uncontrolled manic-depressive illness) as assessed by history and/or clinical interview
- Serious medical, psychiatric or non-opioid substance use disorder that, in the opinion of a study physician, would make study participation hazardous to the participant or compromise study findings or would prevent the participant from completing the study. Examples include: (a) Disabling or terminal medical illness (e.g., uncompensated heart failure, cirrhosis or end-stage liver disease) as assessed by medical history, review of systems, physical exam and/or laboratory assessments
- Patients:
- Current severe alcohol, benzodiazepine, or other depressant or sedative hypnotic use likely to require a complicated medical detoxification (routine alcohol and sedative detoxifications may be included)
- Suicidal or homicidal ideation that requires immediate attention
- Presence of pain of sufficient severity as to require ongoing pain management with opioids
- Pending legal action or other reasons that might prevent an individual from completing the study
- Pregnancy as assessed by urine pregnancy testing
- Breastfeeding of infants, as assessed by self-report
- Prisoners, as defined by OHRP, are excluded from participation in the study
- none; Clinician Participants
- none
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
This trial is currently available in United States.
- NYU LangoneNew York, United StatesContact: Paul GlimcherTaking people
- Rutgers UniversityPiscataway, United StatesContact: Anna Konova, MDNot yet recruiting
About the trial
What the trial wants to find out
Treatments for opioid addiction exist, but effectiveness is compromised when subjects use illicit opiates during treatment. Reuse rates during treatment can be high, and reducing illicit opiate use during treatment has thus recently become a major NIDA policy goal. The 5-minute battery indicates the numerical probability that a patient will reuse illicit opiates within the next 7-10 days.
The 5 groups in the trial
- Treatment-as-UsualNo study treatment, for comparison
Participants will receive the same treatment as if they had not joined the study
- Smartphone with dose changes after usingTreatment being tested
Participants will have an app installed on their phone and have to complete a brief questionnaire and some days play a 2-4 minute game.
Treatment: Smartphone app
- Smartphone with dose changes before usingTreatment being tested
Participants will have an app installed on their phone and have to complete a brief questionnaire and some days to play a 2-4 minute game.
Treatment: Smartphone app
- Focus group with Study PhysicansTreatment being tested
Study physicians asked to participate in a focus group session or 1:1 interviews if unable to attend the focus group during year one of the study and once annually towards the end of years 2, 3, 4, and 5 of the study
Treatment: Smartphone app
- Focus group with CliniciansTreatment being tested
Clinicians asked to participate in a 1:1 interview and a separate focus group at roughly the same time. Prior to the first structured interview with our study team, you will participate in a 1-hour training and familiarization session with the SOAR system using synthetic or training data.
Treatment: Smartphone app
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT05033028, who can take part
- Record updated
- 23 June 2026